Literature DB >> 20310043

Conditional relative survival in head and neck squamous cell carcinoma: Permanent excess mortality risk for long-term survivors.

Marc P van der Schroeff1, Saskia A M van de Schans, Jay F Piccirillo, Ton P M Langeveld, Robert J Baatenburg de Jong, Maryska L G Janssen-Heijnen.   

Abstract

BACKGROUND: Dynamic predictions on head and neck cancer survival could offer, besides improved patient counseling, insight into long-term effects of tumor- and patient-based characteristics on survival. Theoretically, there could be a certain time period after diagnosis after which the patient returns to a population risk on survival.
METHODS: In all, 7255 patients with a primary head and neck squamous cell carcinoma (HNSCC) aged 25 to 90 years, diagnosed between January 1980 and January 2004 in The Netherlands, were included. Conditional 5-year relative survival for every additional year survived was computed.
RESULTS: The overall conditional relative prognosis reached a plateau after approximately 4 years; a permanent 20% to 25% excess mortality for long-term HNSCC survivors remained.
CONCLUSIONS: Conditional 5-year relative survival for patients with HNSCC remains poorer compared to age- and sex-matched counterparts in the general population, even when alive at 15 years after diagnosis. We assume that this is caused by an excess comorbidity in these patients, mainly due to smoking and alcohol abuse.

Entities:  

Mesh:

Year:  2010        PMID: 20310043     DOI: 10.1002/hed.21369

Source DB:  PubMed          Journal:  Head Neck        ISSN: 1043-3074            Impact factor:   3.147


  14 in total

1.  Real-world cost-effectiveness of cetuximab in locally advanced squamous cell carcinoma of the head and neck.

Authors:  N van der Linden; C W M van Gils; C P Pescott; J Buter; M R Vergeer; C A Uyl-de Groot
Journal:  Eur Arch Otorhinolaryngol       Date:  2014-06-19       Impact factor: 2.503

2.  On the need for comprehensive assessment of impact of comorbidity in elderly patients with head and neck cancer.

Authors:  Afshin Teymoortash; Gyorgy B Halmos; Carl E Silver; Primož Strojan; Missak Haigentz; Alessandra Rinaldo; Alfio Ferlito
Journal:  Eur Arch Otorhinolaryngol       Date:  2014-07-25       Impact factor: 2.503

3.  Causes of death in long-term survivors of head and neck cancer.

Authors:  Shrujal S Baxi; Laura C Pinheiro; Sujata M Patil; David G Pfister; Kevin C Oeffinger; Elena B Elkin
Journal:  Cancer       Date:  2014-02-22       Impact factor: 6.860

4.  Incidence and Risk of Second Primary Malignant Neoplasm After a First Head and Neck Squamous Cell Carcinoma.

Authors:  Eric Adjei Boakye; Paula Buchanan; Leslie Hinyard; Nosayaba Osazuwa-Peters; Mario Schootman; Jay F Piccirillo
Journal:  JAMA Otolaryngol Head Neck Surg       Date:  2018-08-01       Impact factor: 6.223

5.  Cardiovascular risk and prevention in patients with head and neck cancer treated with radiotherapy.

Authors:  Christian C Okoye; Jessica Bucher; Curtis Tatsuoka; Sahil A Parikh; Guilherme H Oliveira; Michael K Gibson; Mitchell Machtay; Min Yao; Chad A Zender; Jennifer A Dorth
Journal:  Head Neck       Date:  2016-12-29       Impact factor: 3.147

6.  Racial and rural-urban disparities in cardiovascular risk factors among patients with head and neck cancer in a clinical cohort.

Authors:  Amrita Mukherjee; Howard W Wiener; Russell L Griffin; Carrie Lenneman; Arka Chatterjee; Lisle M Nabell; Cora E Lewis; Sadeep Shrestha
Journal:  Head Neck       Date:  2022-04-09       Impact factor: 3.821

7.  Prognostic Factors as a Function of Disease-free Interval After Definitive (Chemo)radiation for Non-Small Cell Lung Cancer Using Conditional Survival Analysis.

Authors:  Jidong Hong; Zhongxing Liao; Yan Zhuang; Lawrence B Levy; Tommy Sheu; John V Heymach; Quynh-Nhu Nguyen; Ting Xu; Ritsuko Komaki; Daniel R Gomez
Journal:  Am J Clin Oncol       Date:  2018-01       Impact factor: 2.339

8.  Prediction of survival with alternative modeling techniques using pseudo values.

Authors:  Tjeerd van der Ploeg; Frank Datema; Robert Baatenburg de Jong; Ewout W Steyerberg
Journal:  PLoS One       Date:  2014-06-20       Impact factor: 3.240

9.  The impact of second primary malignancies on head and neck cancer survivors: a nationwide cohort study.

Authors:  Li-Jen Liao; Hsu-Wen Chou; Chi-Te Wang; Chen-Shuan Chung; Mei-Shu Lai
Journal:  PLoS One       Date:  2013-04-16       Impact factor: 3.240

10.  Extrapolation of Survival Curves from Cancer Trials Using External Information.

Authors:  Patricia Guyot; Anthony E Ades; Matthew Beasley; Béranger Lueza; Jean-Pierre Pignon; Nicky J Welton
Journal:  Med Decis Making       Date:  2016-09-29       Impact factor: 2.583

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.